Intranasal Immunization of a DNA Vaccine with IL-12- and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Expressing Plasmids in Liposomes Induces Strong Mucosal and Cell-Mediated Immune Responses Against HIV-1 Antigens

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3638-3647

  Okada, Eiichi ^a   Sasaki, Shin ^a,b   Ishii, Norihisa ^a   Aoki, Ichiro ^c   Yasuda, Tatsuji ^d   Nishioka, Kusuya ^e   Fukushima, Jun ^a   Miyazaki, Jun Ichi ^f   Wahren, Britta ^g   Okuda, Kenji ^a,c  

^a Department of Bacteriology ^*  (Japan)

^b Oita Medical University   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e Viral Hepatitis Foundation of Japan   (Japan)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; DRUG CARRIER; GAG PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; INTERLEUKIN 12; LIPOSOME;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELL FUSION; CELLULAR IMMUNITY; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MOLECULAR GENETICS; MOUSE; MUCOSAL IMMUNITY; PHYSIOLOGY; PLASMID;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; CELL FUSION; CYTOKINES; DRUG CARRIERS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV ANTIBODIES; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-12; LIPOSOMES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

EID: 0031252387     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Okuda. K., H. Bukawa, K. Hamajima, S. Kawamoto, K. Sekigawa, Y. Yamada, S.-I. Tanaka, N. Ishii, I. Aoki, M. Nakamura, H. Yamamoto, B. R. Cullen, and J. Fukushima. 1995. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Rev. Hum. Retroviruses 11:933.
2. Bukawa, H., K. Sekigawa, K. Hamajima, J. Fukushima, Y. Yamada, H. Kiyono, and K. Okuda. 1995. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:681.
3. Lue, C., A. W. L. van Den Wall Bake, S. J. Prince, B. A. Julian, M.-L. Tseng, J. Radl, C. O. Eison, and J. Mestecky. 1994. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit secretory IgA responses. Clin. Exp. Immunol. 96:356.
4. Lehner, T., L. Tao, C. Panagiotidi, L. S. Klavinskis, R. Brookes, L. Hussain, N. Meycers, S. E. Adams, A. J. H. Gearing, and L. S. Bergmeier. 1994. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1624.
5. Staats, F. H., W. G. Nichols, and T. J. Palker. 1996. Systemic and vaginal anti-body responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462.
6. Lehner, T., L. A. Bergmeier, C. Panagiotidi, L. Tao, R. Brookes, L. S. Kavinskis, P. Walker, J. Walker, R. G. Ward, L. Hussain, A. J. H. Gearing, and S. E. Adams. 1992. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258:1365.
7. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323.
8. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Bayaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621.
9. Tamura, S.-I., H. Asanuma, Y. Ito, Y. Hirahayashi, Y. Suzuki, T. Nagamine, C. Aizawa, T. Kurata, and Y. Oya. 1992. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza HA vaccine. Eur. J. Immunol. 22:477.
10. Wheeler, C. J., P. L. Felgner, Y. J. Tsai, J. Marshall, L. Sukhu, S. G. Doh, J. Hartikka, J. Nietupski, M. Manthorpe, M. Nichols, M. Plewe, X. Liang, J. Norman, A. Smith, and S. E. Cheng. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93:11454.
11. Wang, B., J. Boyer, V. Srikantan, L. Coney, R. Carrano, C. Phan. M. Merva, K. Dang, M. Agadijanan, L. Gilbert, K. E. Ugen, W. V. Williams, and D. B. Weiner. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:799.
12. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadijanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immunoresponses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 90:4156.
13. Donnelly, J. J., A. Fridman, D. Martines, D. L. Montgomery, J. W. Shiver, S. L. Motzel, J. B. Ulmer, and M. A. Liu. 1995. Preclinical efficacy of a protype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:583.
14. Bangham A. D. 1963. Physical structure and behavior of lipids and enzymes. Adv. Lipid Res. 1:65.
15. Straubinger R. M., and B. Papahadjopoulos. 1983. Liposome as carrier for intracellular delivery of nucleic acids. Methods Enzymol. 101:512.
16. Presant, C. A., D. Blayney, R. T. Proffitt, A. Turner, E. Williams, H. I. Nadel, P. Kennedy, C. Wiseman, K. Gala, R. J. Crossley, S. J. Preiss, G. E. Ksionski, and S. L. Presant. 1990. Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium 111-labelled liposomes. Lancet 335:1307.
17. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotoh, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schiltz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninjected Gambian women. Nat. Med. 1:59.
18. Clerici, M., J. V. Giorge, C.-C. Chore, V. K. Gudeman, F. A. Zack, P. Gupta, H.-N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type-1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
19. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21.
20. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
21. + T cells from αβ-TCR transgcnic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119.
22. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
23. Wynn, T. A., D. Jankovic, S. Hienty, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.
24. Gazzinelli, R. T., N. A. Giese, and H. C. Morse III. 1994. In vivo treatment of interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:2199.
25. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
26. Tsuji, T., K. Hamajima, J. Fukushima, K.-Q. Xin, N. Ishii, I. Aoki, Y. Ishigatsubo, K. Tani, S. Kawamoto, Y. Nitta, J. Miyazaki, W. C. Koff, T. Okubo, and K. Okuda. 1997 Enhancement of cell-mediated immunity against HIV-1 induced by coinoculalion of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158:4008.
27. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.
28. Davis, M. L., H. Bernhard, F. M. Shiota, S. L. Hand, J. R. Gralow, E. S. Huseby, S. Gillis, and M. A. Cheever. 1996. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccine. Blood 88:202.
29. Koga, Y., H. Sasaki, H. Yoshida, H. Wigzell, G. Kimura, and K. Nomoto. 1990. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotcin of HIV. J. Immunol. 144:94.
30. Boucher, C. A. B., W. J. Krone, J. Goudsmit, R. H. Meloen, P. H. Naylor, A. L. Goldstein, D. K. Sun, and P. S. Sarin. 1990. Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP 30. J. Clin. Lab. Anal. 4:43.
31. Malim, M. H., J. Hauber, R. Fenrick, and B. R. Cullen. 1988. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335:181.
32. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193.
33. Attman, A. S., G D. Johnson, and M. B. Prystowky. 1991 Single proline substitutions in predicted α-helices of murine granulocyte-macrophage colony-stimulating factor resulted in a loss in bioactivity and altered glycosylation. J. Biol. Chem. 266:5333.
34. Gao, X., and L. Huang. 1991. A novel cationic reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:280.
35. Wolff, J. A., P. Williams, G. Acsadi, S. Jiao, A. Jani, and W. Chong. 1991. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 11:474.
36. Tamura, S.-I., Y. Samegai, H. Kurata, T. Nagamine, C. Aizawa, and T. Kurata. 1988. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 6:409.
37. Okuda, K., H. Bukawa, S. Kawamoto, M. Imai, T. Saito, P. Phanuphak, and K. Hamajima. 1994. A serologic analysis and amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok. J Infect. Dis. 169:227.
38. Okuda, K., T. Kaneko, T. Yamakawa, S. Tanaka, T. Shigematsu, A. Yamamoto, K. Hamajima, K. Nakajima, S. Kawamoto, and P. Phanuphak. 1993. Strong immunogenicily of a multicomponent vaccine developed with the branched lysine oligopeptide (BLO) method for human immunodeficiency virus-1 (HIV-1) infection. J. Mol. Recognit. 6:101.
39. Shirai, A., V. Sierra, C. I. Kelly, and D. Klinman. 1994. Individual cells simultaneously produce both 1L-4 and IL-6 in vivo. Cytokine 6:329.
40. Okuda, K., N. Ishii, Z., Ikezawa, T. Takahashi, K. Arai, and I. Tadokoro. 1982. Delayed type hypersensitivity to hen egg-white lysozyme. I. The surface phenotypes of suppressor T cells induced by intravenous infection of lysozyme-modified spleen cells and their molecular interactions. Microbiol. Immunol. 26:897.
41. Piccotti, J. R., S. Y. Chan, R. E. Goodman, J. Magram, H. J. Eichwald, and D. K. Bishop. 1996. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. J. Immunol. 157:1951.
42. Aliberti J. C. S., M. A. G. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Q. Vieira, and J. S. Silva. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1961.
43. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralisation of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. J. Immunol. 152:1883.
44. Layton, G. T., S. J. Harris, A. J. Gearing, P. M. Hill, J. S. Cole, J. C. Griffiths, N. R. Burns, A. J. Kingstman, and S. E. Adams. 1993. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3: type of virus-like particles. J. Immunol. 151:1097.
45. Takahashi, H., R. N. Germain, B. Moss, and J. A. Berzofsky. 1990. An immunodominant class I-resiricled cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 II-restricted help for itself. J. Exp. Med. 171:571.
46. Gorai, I., M. Aihara, G. S. Bixler, M. Z. Atassi, P. Walden, and J. Klein. 1988. T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur. J. Immunol. 18:1329.
47. Clerici, M., D. R. Lucey, R. A. Zajac, R. N. Boswell, H. M. Gebel, H. Takahashi, J. A. Berzofsky, and G. M. Shearer. 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146:2214.
48. Porgador A., H. S. Staats, B. Faiola, E. Gilbon, and T. J. Palker. 1997. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specilic CTLs and protection against tumor development in vivo. J. Immunol 158:834.
49. Hirabayashi, Y., H. Kurata, H. Funato, T. Nagamine, C. Aizawa, S. Tamura, K. Shimada, and T. Kurata. 1990. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8:243.
50. Pal, S., T. J. Fielder, E. M. Peterson, and L. M. De La Maza. 1994. Protection against infertility in a BALB/c mouse salpengitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 62:3354.
51. Kats, J., C. C. Harmon, G. P. Buckner, G. J. Richardson, M. W. Russell, and S. M. Michalek. 1993. Protective salivary immunoglohulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Inject. Immun. 61:1964.
52. Takahashi, I., N. Okahashi, T. Kanamoto, H. Asakawa, and T. Koga. 1990. Intranasal immunization of mice with recombinant protein antigen of serotype C Streptococcus mutans and cholera toxin B subunit. Arch. Oral Biol. 35:475.
53. Fujihashi, K., J. R. McGhee, M. Yamamoto, T. Hiroi, and H. Kiyono. 1996. Role of gamma delta T cells in the regulation of mucosal IgA response and oral tolerance. Ann. NY Acad. Sci. 778:55.
54. + T-cell subsets in vivo, Immunol. Rev. 123:189.
55. Mor, G., M. Singla, A. D. Steinberg, S. L. Hoffman, K. Okuda, and D. M. Klinman. 1997. Do DNA vaccine induce autoimmune disease? Hum. Gene Ther. 8:298.
56. Valiante, N. M., M. Rengaraju, and G. Trinchieri. 1992. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of the B cell lines to stimulate T and NK cell proliferation. Cell. Immunol. 145:187.